AI-CVD vs RX-1 Rhythm Express Remote Cardiac Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-CVD

by HeartLung AI

RX-1 Rhythm Express Remote Cardiac Monitoring System

by VivaQuant, Inc.

AI Verdict

AI-CVD focuses on opportunistic screening for structural cardiovascular risks by analyzing existing CT scans, identifying issues like coronary artery calcium and cardiac chamber abnormalities. In contrast, the RX-1 Rhythm Express system provides continuous, remote ECG monitoring via a wearable device to detect and characterize cardiac arrhythmias. While both leverage AI in cardiology, they address distinct diagnostic needs: one for anatomical risk assessment and the other for electrical activity monitoring.

Choose AI-CVD if…

Choose AI-CVD if your primary objective is to perform opportunistic screening for cardiovascular and multisystem diseases using existing CT scans. This platform is ideal for identifying hidden health risks like coronary artery calcium or cardiac chamber abnormalities without requiring additional patient imaging or workflow disruption. It's best suited for leveraging previously acquired imaging data for early detection and risk stratification.

View AI-CVD →

Choose RX-1 Rhythm Express Remote Cardiac Monitoring System if…

Choose RX-1 Rhythm Express if you require continuous, high-fidelity ECG monitoring for patients suspected of having cardiac arrhythmias. This wearable device is excellent for capturing transient or infrequent arrhythmias over extended periods, providing near real-time data transmission for prompt diagnosis and management. It's particularly useful for patients needing mobile cardiac telemetry, event recording, or extended Holter monitoring.

View RX-1 Rhythm Express Remote Cardiac Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-CVD	RX-1 Rhythm Express Remote Cardiac Monitoring System
Pricing	Unknown	Available
Deployment	Unknown	Cloud-based
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-CVD

AI-CVD leverages existing CT scans for opportunistic screening, requiring no additional imaging, radiation, contrast, or workflow disruption, making it highly integrated and low-friction for both patients and clinicians. In contrast, RX-1 Rhythm Express, while designed for patient comfort, still requires active patient participation in wearing a device.

Clinical Value

AI-CVD

AI-CVD offers broad, opportunistic screening for multiple cardiovascular and multisystem diseases (e.g., CAC scoring, cardiac chamber volumetry, epicardial fat, liver steatosis, bone mineral density) from existing CT scans, enabling early detection of hidden health risks across a wider range of conditions without additional procedures. RX-1 Rhythm Express provides highly accurate and continuous monitoring specifically for arrhythmia detection, which is valuable but more narrowly focused.

Pricing & Value

RX-1 Rhythm Express Remote Cardiac Monitoring System

RX-1 Rhythm Express offers transparent and flexible pricing models, including subscription, fee-for-service, and split-bill options, allowing clinics to choose the model that best fits their financial structure. AI-CVD, on the other hand, requires contacting the vendor for pricing, which offers less transparency upfront.

Enterprise Readiness

RX-1 Rhythm Express Remote Cardiac Monitoring System

RX-1 Rhythm Express explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for secure and legal operation within healthcare enterprises. While AI-CVD is FDA-cleared and cloud-deployed, its compliance claims for HIPAA and BAA are stated as 'likely, contact vendor,' providing less definitive assurance for enterprise adoption.

Innovation

AI-CVD

AI-CVD demonstrates significant innovation by transforming existing, often underutilized, CT scan data into a powerful, proactive, and multisystem screening tool without any additional patient or workflow burden. This opportunistic screening approach represents a paradigm shift in early disease detection. RX-1 Rhythm Express innovates through its proprietary MDSP technology for superior signal quality and AI-enabled arrhythmia detection in a wearable, enhancing an existing monitoring paradigm.

Support & Docs

RX-1 Rhythm Express Remote Cardiac Monitoring System

VivaQuant's RX-1 Rhythm Express provides readily accessible user and clinician manuals, offering detailed instructions for device use, troubleshooting, and safety information. In contrast, public information regarding specific support channels or comprehensive documentation for HeartLung Corporation's AI-CVD is not readily available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-CVD	RX-1 Rhythm Express Remote Cardiac Monitoring System
Product Name	AI-CVD	RX-1 Rhythm Express Remote Cardiac Monitoring System
Company	HeartLung Corporation	VivaQuant
Core Function	AI-powered quantitative imaging platform for opportunistic screening for cardiovascular and multisystem diseases using existing CT scans.	FDA-cleared, patch-style wearable device offering continuous ECG monitoring in MCT, Event, and Holter modes.
Primary Data Source	Existing chest and abdominal CT scans	Continuous 2-channel ECG monitoring from a wearable device
Key Analytical Capability	Automated CT-derived anatomical and density-based measurements, Coronary Artery Calcium (CAC) scoring, Cardiac chamber volumetry	Proprietary Multi-Domain Signal Processing (MDSPu2122) technology for noise suppression, AI-enabled advanced signal processing for arrhythmia detection

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and RX-1 Rhythm Express Remote Cardiac Monitoring System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in how these tools gather patient data for cardiac assessment?

AI-CVD utilizes existing CT scans to perform opportunistic screening for cardiovascular and multisystem diseases, leveraging previously acquired imaging data. In contrast, the RX-1 Rhythm Express gathers patient data through a patch-style wearable device that provides continuous ECG monitoring.

What specific types of cardiovascular conditions or risks do these tools help detect?

AI-CVD focuses on detecting hidden health risks through measurements like Coronary Artery Calcium (CAC) scoring, aortic/mitral valve calcification, cardiac chamber volumetry, and epicardial fat volumetry. RX-1 Rhythm Express specializes in detecting various arrhythmias through continuous ECG monitoring.

How do these tools integrate into existing clinical workflows?

AI-CVD is designed for opportunistic screening using existing CT scans, aiming for no additional imaging, radiation, contrast, or workflow disruption. RX-1 Rhythm Express involves a patient-worn device that transmits data near real-time to a cloud platform for physician review, integrating remote monitoring into the workflow.

Which medical specialties are these tools primarily designed for?

AI-CVD is applicable across Cardiology, Pulmonology, and Radiology due to its broad opportunistic screening capabilities from existing CT scans. RX-1 Rhythm Express is primarily focused on Cardiology, specializing in remote cardiac monitoring for arrhythmia detection.